4.7 Review

Peptidomimetics in cancer targeting

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging

Richard Laforest et al.

Summary: There is an unmet need for targeted imaging agents for multiple myeloma (MM). The radiopharmaceutical 64Cu-LLP2A, which targets VLA4, has shown potential for managing MM patients. This study evaluated the safety and radiation dosimetry of 64Cu-LLP2A in MM patients.

JOURNAL OF NUCLEAR MEDICINE (2023)

Article Biochemical Research Methods

Characterization of folic acid-functionalized PLA-PEG nanomicelle to deliver Letrozole: A nanoinformatics study

Neda Rostami et al.

Summary: Effective cancer treatment is the top challenge for human health, with nanotechnology emerging as a promising new method for targeting cancer cells. The study found that PLA-PEG-FA can enhance the effectiveness of Letrozole in inhibiting breast cancer cells by increasing stability and cell membrane permeability.

IET NANOBIOTECHNOLOGY (2022)

Review Oncology

Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis

RamaRao Malla et al.

Summary: The interplay between cancer stem cells, exosomes, and circulatory tumor cells in breast cancer has been discussed. They communicate with stromal and immune cells to promote metastasis and induce epithelial mesenchymal transition (EMT) involved in metastasis.

CLINICAL BREAST CANCER (2022)

Review Clinical Neurology

A hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways

Meric A. Altinoz et al.

Summary: Meperidine has unique anticancer properties by inhibiting specific receptors and enzymes, while tamoxifen enhances the anticancer effect by blocking proteins and regulating lipid levels. The combination of meperidine and tamoxifen may have a synergistic relationship in the treatment of glioblastoma.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Review Pharmacology & Pharmacy

Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective

Kunal S. Taskar et al.

Summary: This article discusses the role of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in drug-drug interactions, drug absorption, and brain penetration. Based on clinical evidence, the article suggests that inhibition of P-gp or BCRP in the liver or kidneys has limited clinical implications on drug disposition.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Pharmacology & Pharmacy

Recent advances in anti-multidrug resistance for nano-drug delivery system

Changduo Wang et al.

Summary: Chemotherapy often fails due to drug resistance. To overcome this, researchers have developed a functional nano-drug delivery system (NDDS) that enhances the sensitivity of anticancer drugs and reduces side effects. This review explores the causes of multidrug resistance (MDR), highlights the applications of NDDS, and discusses future directions in this field.

DRUG DELIVERY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy

Dirk Zboralski et al.

Summary: The study confirms the high expression of FAP-2286 in multiple tumor types and demonstrates its ability to have persistent uptake and retention in FAP-positive tumors, suggesting its potential for imaging and therapeutic applications.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Chemistry, Medicinal

Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors

Giovanna Li Petri et al.

Summary: This article outlines the latest efforts and synthetic strategies in the development of peptidomimetic drugs, as well as their biological evaluation against a range of targets.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

The potential roles of retinoids in combating drug resistance in cancer: implications of ATP-binding cassette (ABC) transporters

Mohamed R. Abdelaal et al.

Summary: Multidrug resistance (MDR) refers to the phenomenon where tumor cells become unresponsive to one or more chemotherapeutic drugs during or after treatment. This critically limits treatment outcomes and poses a major challenge for clinicians. Alterations in intracellular drug concentration through the modulation of drug transport across the plasma membrane is the main cause of MDR, and this process involves various mediators, including ATP-requiring enzymes (ATPases). Among these ATPases, ABC transporters have been extensively studied and found to be highly implicated in tumorigenesis and MDR. This review focuses on the effects of retinoids on ABC enzymes and aims to understand their mechanism in combating cancer cell resistance.

OPEN BIOLOGY (2022)

Review Chemistry, Medicinal

Peptidomimetics in Silico

Cristina Tomasella et al.

Summary: Researchers are interested in using chemical modification to produce peptidomimetics that can modulate molecular interactions, with recent studies focusing on the discovery of these compounds through computational methods. Molecular dynamic simulations and pharmacophore research simulations are valuable tools in understanding the molecular determinants underlying physiological processes.

MOLECULAR INFORMATICS (2021)

Review Oncology

Bioactive Peptides as Therapeutic Adjuvants for Cancer

Nidia Quintal-Bojorquez et al.

Summary: This review discusses the potential of bioactive peptides from natural sources in cancer treatment, with peptides obtained by enzymatic hydrolysis showing anticancer effects and immunomodulatory activities in experiments. However, the lack of standardized extraction procedures and pharmacokinetic profiles calls for further clinical trials to confirm these effects.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells

Satya Prakash Shukla et al.

Summary: The study identified a highly specific peptidomimetic PCS2D1.2 that displayed highly specific cytotoxicity towards CSCs, effectively blocking colony formation and cell migration of CSCs without affecting non-CSCs. Furthermore, PCS2D1.2 reduced plectin expression and/or plectin-rich CSCs in both in vitro and in vivo studies, showing potential as a highly CSC specific drug candidate for combination therapy with current anti-cancer drugs.

BIOORGANIC CHEMISTRY (2021)

Review Oncology

Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting

Muhammad Abdur Rahim et al.

Summary: This review focuses on improving the targeting of anticancer agents in the tumor microenvironment through stimuli-responsive drug delivery systems, discussing physical and chemical stimuli-responsive systems for active and passive targeting. Recent advancements in onco-targeted therapies have allowed for safe and effective tumor-specific localization, revolutionizing chemotherapy-based treatments with enhanced bioavailability and selective cytotoxicity.

CANCERS (2021)

Article Chemistry, Medicinal

Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy

Himgauri Naik et al.

Summary: The study demonstrates that SA-5-Dox-LP liposome formulation has the potential to increase therapeutic efficiency and targeted delivery of Dox in HER2 overexpressing cancer. It showed better antiproliferative activity and selective cellular uptake in cancer cells compared to non-targeted liposomes. In vivo studies in an NSCLC mouse model also revealed significant reduction of lung tumors with SA-5-Dox-LP.

PHARMACEUTICALS (2021)

Review Immunology

Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer

Maoyu Xiao et al.

Summary: The article summarizes the crucial role of tumor-associated macrophages (TAMs) in breast cancer treatment, and discusses the potential of targeting TAMs through various approaches to reduce drug resistance.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Multi-Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation

Liting Wang et al.

Summary: This study identifies a novel inhibitor of DR6/APP interaction as a promising anti-hematogenous metastatic agent, which exhibits strong binding potency and excellent pharmacokinetic properties. The compound efficiently protects vascular endothelial cells from necroptosis induced by tumor cells and demonstrates significant anti-hematogenous metastatic activity in multiple metastatic mouse models.

ADVANCED SCIENCE (2021)

Article Toxicology

Implementation of docking, molecular dynamics and free energy to investigate drug potency of novel BCR-ABLT315I inhibitors as an alternative to ponatinib

Mohammad Mahmoudi Gomari et al.

Summary: Today, a significant portion of healthcare costs is dedicated to cancer diagnosis and treatment. Despite considerable advances in cancer research, drug resistance remains a major challenge, especially in the case of Chronic Myeloid Leukemia (CML) due to mutations in the target molecules. New compounds like PBA2, CD-200 and JNJ-26854165 show potential in inhibiting BCR-ABLT315I, but Ponatinib remains the most potent inhibitor in targeting the mutant BCR-ABLT315I.

COMPUTATIONAL TOXICOLOGY (2021)

Review Chemistry, Organic

Solid-phase Synthesis of Peptidomimetics with Peptide Backbone Modifications

Aizhan Abdildinova et al.

Summary: Peptidomimetics are compounds with promising pharmacological properties that overcome limitations of peptides through backbone modifications. Accessible synthetic methodologies play a key role in peptidomimetic progress, with solid-phase organic synthesis serving as a powerful tool for their preparation. Numerous strategies for peptide backbone modifications via solid-phase synthesis have been developed in the last two decades.

ASIAN JOURNAL OF ORGANIC CHEMISTRY (2021)

Review Biotechnology & Applied Microbiology

CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations

Mohammad Mahmoudi Gomari et al.

Summary: CD44 plays essential roles in cancer initiation, metastasis, and tumorigenesis, but its validity as a therapeutic or diagnostic target is not fully confirmed. The association of specific SNPs and variants in the CD44 gene with cancer risk remains controversial.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2021)

Article Biochemistry & Molecular Biology

Peptidomimetics: A Synthetic Tool for Inhibiting Protein-Protein Interactions in Cancer

Lloyd Mabonga et al.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2020)

Article Biochemistry & Molecular Biology

Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors

Isaac O. Donkor et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Review Chemistry, Multidisciplinary

Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies

A. C. Marques et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Review Chemistry, Multidisciplinary

Polyamide Backbone Modified Cell Targeting and Penetrating Peptides in Cancer Detection and Treatment

Sunil S. Shah et al.

FRONTIERS IN CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals

Brendan J. Evans et al.

MOLECULES (2020)

Review Biotechnology & Applied Microbiology

Opportunities and challenges of the tag-assisted protein purification techniques: Applications in the pharmaceutical industry

Mohammad Mahmoudi Gomari et al.

BIOTECHNOLOGY ADVANCES (2020)

Article Dermatology

Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results

Steven Kempers et al.

JOURNAL OF DRUGS IN DERMATOLOGY (2020)

Review Chemistry, Multidisciplinary

Peptidomimetic toolbox for drug discovery

Elena Lenci et al.

CHEMICAL SOCIETY REVIEWS (2020)

Review Cell Biology

Targeting siRNA in colorectal cancer therapy: Nanotechnology comes into view

Shahin Aghamiri et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Chemistry, Multidisciplinary

A Guanidyl-Based Bivalent Peptidomimetic Inhibits K-Ras Prenylation and Association with c-Raf

Mai Tsubamoto et al.

CHEMISTRY-A EUROPEAN JOURNAL (2019)

Review Infectious Diseases

Short Cationic Peptidomimetic Antimicrobials

Rajesh Kuppusamy et al.

ANTIBIOTICS-BASEL (2019)

Article Chemistry, Organic

Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-alpha-amanitin conjugates for tumor-targeting

Lizeth Bodero et al.

BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2018)

Review Chemistry, Medicinal

Recent advances in peptidomimetics antagonists targeting estrogen receptor alpha-coactivator interaction in cancer therapy

Weirong Qin et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Review Cell Biology

Breast cancer diagnosis: Imaging techniques and biochemical markers

Seyed Hamed Jafari et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Article Multidisciplinary Sciences

Peptidomimetic blockade of MYB in acute myeloid leukemia

Kavitha Ramaswamy et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells

Wadie D. Mahauad-Fernandez et al.

SCIENTIFIC REPORTS (2018)

Review Microbiology

Promising Antibiofilm Activity of Peptidomimetics

Rafael Gomes Von Borowski et al.

FRONTIERS IN MICROBIOLOGY (2018)

Article Chemistry, Medicinal

Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2+cancer

Himgauri Naik et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells

Sandeep Pallerla et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Oncology

The proprotein convertase furin in tumour progression

Patricia Jaaks et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Review Oncology

Exploring the Role of RGD-Recognizing Integrins in Cancer

Markus Nieberler et al.

CANCERS (2017)

Article Multidisciplinary Sciences

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

Michiru Nishita et al.

SCIENTIFIC REPORTS (2017)

Review Chemistry, Multidisciplinary

From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane

Akira Mizuno et al.

CHEMISTRY-A EUROPEAN JOURNAL (2017)

Review Pharmacology & Pharmacy

Peptidomimetic therapeutics: scientific approaches and opportunities

Nir Qvit et al.

DRUG DISCOVERY TODAY (2017)

Review Biochemistry & Molecular Biology

Dynamic Docking of Conformationally Constrained Macrocycles: Methods and Applications

Scott E. Allen et al.

ACS CHEMICAL BIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366

Calogero D'Alessandria et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)

Article Chemistry, Medicinal

Facile synthesis and 18F-radiolabeling of α4β1-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates

Daniel Walker et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Medicinal

Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469

Qiao-Hong Xia et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Chemistry, Medicinal

Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review

Emanuela Teveroni et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2016)

Review Chemistry, Multidisciplinary

Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes

Marta Pelay-Gimeno et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Article Chemistry, Medicinal

Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent

Young-Seung Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Oncology

Macrophages and Therapeutic Resistance in Cancer

Brian Ruffell et al.

CANCER CELL (2015)

Article Chemistry, Multidisciplinary

Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers

Alberto Dal Corso et al.

CHEMISTRY-A EUROPEAN JOURNAL (2015)

Article Multidisciplinary Sciences

ADAM8 as a drug target in pancreatic cancer

Uwe Schlomann et al.

NATURE COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

A small molecule peptidomimetic that binds to c-KIT1 G-quadruplex and exhibits antiproliferative properties in cancer cells

Ajay Chauhan et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Chemistry, Multidisciplinary

Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo

Ruchi Bansal et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Article Chemistry, Medicinal

Design, Synthesis, and Structure-Activity Relationship Studies of a Potent PACE4 Inhibitor

Anna Kwiatkowska et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates

Wissam Beaino et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Article Chemistry, Multidisciplinary

High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein-Protein Interaction

Hacer Karatas et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)

Article Chemistry, Medicinal

Synthesis and characterization of αvβ3-targeting peptidomimetic chelate conjugates for PET and SPECT imaging

Young-Seung Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Multidisciplinary

Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands

Mattia Marchini et al.

CHEMISTRY-A EUROPEAN JOURNAL (2012)

Article Pharmacology & Pharmacy

Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic

Bin Ma et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)

Article Chemistry, Multidisciplinary

Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity

Paul M. Levine et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Chemistry, Medicinal

Mimicking Peptides... In Silico

Matteo Floris et al.

MOLECULAR INFORMATICS (2012)

Review Medicine, Research & Experimental

RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis

Fabienne Danhier et al.

MOLECULAR PHARMACEUTICS (2012)

Review Pharmacology & Pharmacy

Integrins as therapeutic targets

Simon L. Goodman et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Article Engineering, Biomedical

Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel

Anat Eldar-Boock et al.

BIOMATERIALS (2011)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

Using Modularly Assembled Ligands To Bind RNA Internal Loops Separated by Different Distances

Jessica L. Childs-Disney et al.

CHEMBIOCHEM (2011)

Article Cell Biology

The role of β3-integrins in tumor angiogenesis: context is everything

Stephen D. Robinson et al.

CURRENT OPINION IN CELL BIOLOGY (2011)

Article Biochemistry & Molecular Biology

Structural and Dynamic Determinants of Protein-Peptide Recognition

Onur Dagliyan et al.

STRUCTURE (2011)

Article Oncology

Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation

Carlos Mas-Moruno et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

A Conformationally Constrained Peptidomimetic Binds to the Extracellular Region of HER2 Protein

Sashikanth Banappagari et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2010)

Review Chemistry, Multidisciplinary

Ligands for Mapping αvβ3-Integrin Expression in Vivo

Margret Schottelius et al.

ACCOUNTS OF CHEMICAL RESEARCH (2009)

Article Chemistry, Multidisciplinary

Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands

Ana Sofia M. da Ressurreicao et al.

CHEMISTRY-A EUROPEAN JOURNAL (2009)

Review Radiology, Nuclear Medicine & Medical Imaging

Multimodality molecular imaging of tumor angiogenesis

Weibo Cai et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Biochemical Research Methods

Identification and Rational Redesign of Peptide Ligands to CRIP1, A Novel Biomarker for Cancers

Jihua Hao et al.

PLOS COMPUTATIONAL BIOLOGY (2008)

Review Oncology

Integrins in angiogenesis and lymphangiogenesis

Christie J. Avraamides et al.

NATURE REVIEWS CANCER (2008)

Article Biochemistry & Molecular Biology

Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease

Johanna Lahdenranta et al.

FASEB JOURNAL (2007)

Review Pathology

Apoptosis: A review of programmed cell death

Susan Elmore

TOXICOLOGIC PATHOLOGY (2007)

Review Peripheral Vascular Disease

Angiogenesis in cancer

Naoyo Nishida et al.

VASCULAR HEALTH AND RISK MANAGEMENT (2006)

Review Pharmacology & Pharmacy

Targeting RGD recognizing integrins: Drug development, biomaterial research, tumor imaging and targeting

A. Meyer et al.

CURRENT PHARMACEUTICAL DESIGN (2006)

Article Biochemistry & Molecular Biology

Antitumor effect of RGD-4C-GG-D(KLAKLAK)(2) peptide in mouse B16(F10) melanoma model

Ryszard Smolarczyk et al.

ACTA BIOCHIMICA POLONICA (2006)

Review Pharmacology & Pharmacy

Cutting back on pro-protein convertases:: the latest approaches to pharmacological inhibition

M Fugère et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2005)

Article Oncology

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247

KE Shannon et al.

CLINICAL & EXPERIMENTAL METASTASIS (2004)

Review Chemistry, Multidisciplinary

Carbohydrate-based mimetics in drug design: Sugar amino acids and carbohydrate scaffolds

SAW Gruner et al.

CHEMICAL REVIEWS (2002)

Article Oncology

Involvement of c-Src in carcinoma cell motility and metastasis

M Sakamoto et al.

JAPANESE JOURNAL OF CANCER RESEARCH (2001)

Review Biochemistry & Molecular Biology

Role of Src expression and activation in human cancer

RB Irby et al.

ONCOGENE (2000)

Review Biochemistry & Molecular Biology

New roles for Src kinases in control of cell survival and angiogenesis

J Schlessinger

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.